Metastatic Malignancy Presenting as Thrombotic Thrombocytopenia Purpura; Report of Two Cases

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 136

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PMJ-8-28_001

تاریخ نمایه سازی: 16 اسفند 1401

چکیده مقاله:

BackgroundCancer associated thrombotic microangiopathy (CA-TMA) is a rare diagnosis that while confronting a patient with evidence of microangiopathic hemolytic anemia and thrombocytopenia with normal ADAMTS۱۳ enzyme activity, should be considered. Here we present two cases of cancer associated TMA; breast cancer and gastric cancer.Case presentationCase ۱ was a ۴۰-year-old man presented with abdominal pain, icterus and weight loss and laboratory tests revealed microangiopathic hemolytic anemia. He received ۶ sessions of plasma exchange under diagnosis of thrombotic thrombocytopenic purpura. Bone marrow biopsy and immunohistochemistry revealed clusters of non-hematopoietic cells suggestive of gastrointestinal adenocarcinoma. Case ۲ was a ۵۱-year-old woman whose clinical history and laboratory tests were similar to case ۱ except for a breast mass along with axillary lymphadenopathy. Bone marrow examination revealed clusters of non-hematopoietic cells and core needle biopsy revealed invasive lobular carcinoma.Both patients were unresponsive to plasma exchange and case ۱ unfortunately shortly died after diagnosis but case ۲ is alive and survived after receiving chemotherapy. ConclusionCancer associated TMA can rarely be seen as the first manifestation of a malignancy and causes a diagnostic dilemma for clinicians.The prognosis of CA-TMA is generally poor and initiatingchemotherapy is the only reliable treatment option.

نویسندگان

Hamid Rezvani

Associate professor, Department of Medical Oncology and hematology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mehdi Tabarraee

Assistant professor, Department of Medical Oncology and hematology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mojtaba Ghadyani

Assistant professor, Department of Medical Oncology and hematology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Seyed Amir Sheikholeslami

Department of Medical Oncology and hematology, Imam hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Hamideh Rahmani

Assistant professor, Department of Medical Oncology and hematology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Soude Ramezan Nejad

Hematology and Oncology fellowship, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Aida Iranpour

Assistant professor, Iran university of medical sciences, Tehran, Iran